Cartesian Therapeutics, Inc. (RNAC)
6.75
-0.22
(-3.16%)
USD |
NASDAQ |
Apr 24, 16:00
6.75
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Total Assets (Quarterly) : 296.41M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Precision BioSciences, Inc. | 154.42M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 422.65M |
| Shareholders Equity (Quarterly) | -126.24M |
| Debt to Equity Ratio | -0.1004 |
| Current Ratio | 8.655 |
| Net Debt Paydown Yield | 0.23% |